Dr. Jennifer Park
Associate Professor of Hematology
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
Gene Editing CAR-T Cell Therapy Cell Therapy
Biography
Dr. Park is a pioneer in applying gene editing technologies to leukemia
treatment. Her research explores using CRISPR and other gene editing tools to
create more effective and accessible cell therapies for treatment-resistant
leukemia patients.
Her work represents the cutting edge of leukemia treatment, potentially making
advanced cell therapy available to more patients while improving safety and
effectiveness. She has published extensively on gene editing applications in
cancer treatment.
Education
- MD, PhD • Johns Hopkins University (2012)
Awards & Honors
- • Innovation in Medicine Award
- • Early Career Researcher Award